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Abstract 
Background: The present study investigated the relationships between psychological stress indices and oxidative 
stress marker, also when combined with emergent insulin resistance (IR), in the non‑diabetic, middle‑aged subjects, 
exposed to frequent/chronic psychological stressors.
Methods: Cross‑sectional data from a cohort of non‑diabetic police officers (n = 234; 19F), aged 27–56 years, were 
used. Plasma inflammatory (CRP, TNF‑α), oxidative stress (free 8‑iso‑prostaglandin  F2α; 8‑iso‑PGF2α) markers, and insulin 
were measured. The value of homeostasis model assessment of IR index (HOMA‑IR) was assumed the threshold value 
of IR, i.e. 2.04. Free cortisol in urine and perceived stress (psychological stress indices) were also measured.
Results: In the IR subjects, most biochemical variables, inflammatory markers and urine cortisol were significantly 
higher, as compared to the non‑IR ones. Psychological stress indices were associated with plasma 8‑iso‑PGF2α 
[B = 0.139, 95% CI (0.048, 0.230), p = 0.002, and B = 0.007, 95% CI (0.0006, 0.014), p = 0.03; for perceived stress level and 
cortisol, respectively]. Positive associations were established between plasma 8‑iso‑PGF2α [B = 0.069, 95% CI (0.016–
0.120), p = 0.01] and urine cortisol [B = 0.003, 95% CI (0.0003, 0.005), p = 0.02] with HOMA‑IR. Metabolic syndrome, as 
defined by IDF criteria, was established in 110 study subjects, whereas 136 of them were hypertensive. Waist circum‑
ference [B = 0.056, 95% CI (0.039, 0.074), p < 0.0001], and systolic blood pressure [B = 0.009, 95% CI (0.00003, 0.018), 
p = 0.04] were positively associated with HOMA‑IR, whereas the association of HDL cholesterol [B = − 0.597, 95% CI 
(− 1.139, − 0.055), p = 0.03] was a negative one. Cortisol [OR = 1.007, 95% CI (1.002, 1.012), p = 0.006], and 8‑iso‑PGF2α 
[OR = 1.103, 95% CI (1.010, 1.201), p = 0.02] affected the incidence of IR. After adjustment for metabolic syndrome 
(or its components), age, sex, and current smoking, the effects became non‑significant. Out of metabolic syndrome 
components, waist circumference [OR 4.966, 95% CI (2.29, 10.751), p = 0.00004] and hypertriglyceridemia [OR 1.993, 
95% CI (1.063, 3.736), p = 0.03] increased the chance of IR incidence.
Conclusions: Both psychological stress indices were associated with oxidative stress, but only cortisol with HOMA‑IR. 
In the subjects exposed to frequent/chronic psychological stressors, cortisol and oxidative stress marker affected IR 
incidence, being statistically attenuated, though, following adjustment for metabolic syndrome, or its components.
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Background
Insulin resistance (IR) is believed to be crucially instru-
mental in the development of metabolic syndrome 
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disease (CVD) through the development of abnormal 
glucose and lipid metabolism, hypertension, and pro-
inflammatory status [1]. MetS affects up to 30% of the 
population in the developed countries, while central obe-
sity makes up one of its components, being also a key 
contributor to insulin resistance (IR), type 2 diabetes, and 
increases overall risk of CVD [1, 2].
Psychological stress is recognised as an important 
risk factor status in CVD, diabetes, and MetS [3–5]. The 
Perceived Stress Scale (PSS) is one of the more popu-
lar, subjective tools for assessing psychological stress, 
even though only few studies have addressed the asso-
ciation between perceived stress and diabetes [4, 6, 7]. 
In response to physiological or psychological stressors, 
resulting in the secretion of cortisol from the adrenal 
gland, a cascade of physiological events follows. Hyper-
cortisolism may induce IR, and lead to type 2 diabetes by 
inhibiting insulin secretion, as well as promote develop-
ment of visceral adiposity, while activating lipolysis and 
free fatty acid release [8]. Chronic stress may also impair 
the feedback mechanisms which return these hormonal 
systems to normal, resulting in chronic elevation in corti-
sol levels, though inter-individual differences in the hypo-
thalamic–pituitary–adrenal (HPA) axis function may be 
causally linked to higher hazard of succumbing to certain 
stress-related metabolic disorders [3, 9]. The changes in 
the normal level of cortisol secretion, may account for 
an accelerated metabolic rate and subsequent genera-
tion of reactive oxygen species (ROS), having also been 
associated with a higher level of oxidative stress markers 
[10, 11]. Oxidative stress is deemed of great significance 
in the aetiology origin of many diseases, in view of the 
association of the end products of free radicals-mediated 
oxidative stress with obesity, IR, dyslipidemia, and hyper-
tension [10, 12, 13]. F2-isoprostanes, prostaglandin-like 
molecules generated in vivo are the most reliable mark-
ers of lipid oxidation and its measurement, widely used 
to assess oxidative stress in various diseases. Out of all 
oxidized fatty acids, the 8-iso-prostaglandin  F2α (8-iso-
PGF2α), also referred to as 15-F2t-isoprostane (or iPF2α-
III), has been the most studied isomer, also known as an 
in vivo biomarker of oxidative stress [14]. Published data 
on oxidative stress in humans in relation to IR remain 
scarce and inconclusive. Some cross-sectional stud-
ies had demonstrated in humans a positive association 
between urine 8-iso-PGF2α and IR, even though no such 
relationships were corroborated by other studies [15–17].
In our previous study, we managed to demonstrate 
that perceived stress was associated with coronary 
heart disease (CHD) and MetS [5]. There are no pub-
lished studies, though, taking into account both the 
psychological and oxidative stress, and their relations 
with IR. As police officers are widely acknowledged to 
be exposed to more stressors than individuals pursuing 
other occupations, we set out to assess the associations 
between the indices of psychological stress (self-per-
ception, cortisol level), with oxidative stress, and IR. In 
line with our working hypothesis, psychological stress 
is believed to be associated with increased systemic 
oxidative stress and incidence of IR.
Methods
Study population
We carried out a cross-sectional study on the cohort of 
police officers from the southern region of Poland, who 
had volunteered for CHD screening at the University 
Hospital in Krakow. The present cohort study is focused 
on the police officers, as the individuals particularly 
exposed to a highly stressful occupation. The following 
inclusion criteria were adopted: active work as a police 
officer for a minimum period of 5  years (the median 
duration of work was 15 years (range 6–27), whereas the 
following ones prompted exclusion from the study pro-
tocol: diabetes mellitus, history of myocardial infarction 
or stroke, cancer, congestive heart failure, atrial fibrilla-
tion, current anticoagulant therapy, liver injury, or kid-
ney insufficiency. Subjects with arterial hypertension 
and lipid disorders (defined as the ones previously diag-
nosed and treated with statins, or had serum total choles-
terol > 5.2 mmol/L) were considered eligible. The subjects 
who had quit smoking at least 6 months previously were 
included as non-smokers. As established through the 
interviews individually conducted with each study sub-
ject by the investigators, none of the subjects had been 
following any alternative dietary profile and/or used any 
food supplementation with his standard dietary intake. 
Out of the 240 subjects who underwent medical exami-
nations, ultimately 234 (19F), aged 27–56 years, complied 
with the inclusion criteria.
Physical examination, medical and structured inter-
views were applied to collect personal and clinical 
information. Anthropometric measurements, i.e. circum-
ference of waist and hips, height, and body weight, were 
collected. Obesity was defined as BMI > 30.0 kg/m2, and 
overweight as BMI > 25.0  kg/m2. Atherogenic dyslipi-
demia was construed as: triglycerides ≥ 1.7 mmol/L and 
HDL-cholesterol < 1.03/1.29  mmol/L (men/women). 
MetS was defined in line with the criteria proposed 
by the International Diabetes Federation (IDF), i.e. 
waist circumference ≥ 94/80  cm (men/women), fast-
ing glucose ≥ 5.6 mmol/L, triglycerides ≥ 1.7 mmol/L, or 
specific treatment for this lipid abnormality, HDL-choles-
terol < 1.03 mmol/L in men, and < 1.29 mmol/L in women, 
systolic/diastolic blood pressure ≥ 130/≥ 85  mmHg, or 
treatment of previously diagnosed hypertension [18].
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Clinical tests
Comprehensive results of specific clinical tests, e.g. 
computed tomography coronary angiography, exercise 
electrocardiography, had previously been addressed 
[5]. Imaging studies, aimed at measuring the surro-
gate markers of atherosclerosis [flow-mediated dilation 
[FMD] of brachial artery, and intima-media thickness 
(IMT)] were also completed using an ultrasonograph 
(Sequoia 512, Mountain View, Ca, USA) with a 6 MHz 
linear transducer.
Measurement of self‑perceived stress
Perceived stress was measured with the aid of Cohen’s 
10-item Perceived Stress Scale (PSS-10) in Polish 
adaptation [6]. Specifically structured questions were 
designed to probe the respondents on how unpredict-
able, uncontrollable, and overloaded they actually 
found their lives. Participants were asked to respond to 
each question on a 5-point Likert scale ranging from 0 
(never) to 4 (very often), indicating how often they have 
felt or thought in a certain way within the past month. 
Scale scores ranged 0-40, with the higher scores indi-
cating higher levels of stress. The reliability of the scale 
was assessed by Cronbach’s alpha, while exploratory 
and confirmatory factor analyses were applied to evalu-
ate validity of PSS-10. The PSS-10 demonstrated good 
reliability, as Cronbach’s alpha was 0.85 (0.84–0.86).
Biochemical measurements
Blood sampling was taken between 8:00 a.m. and 8:30 
a.m. (after a 12-h overnight fast). Blood samples were 
collected into the tubes (Becton–Dickinson, Frank-
lin Lakes, NJ, USA) with a clot activator, containing 
3.2% sodium citrate (final blood-to-anticoagulant ratio 
9:1), and into the ones with EDTA (final concentration 
1.8 mg/mL). Following a 10-min long centrifugation at 
3500 rpm, plasma and serum got separated within 1 h.
A 24 h urine samples collection proved a non-feasible 
approach, as the police officers worked shifts. Conse-
quently, the subjects were instructed to pass their urine 
(midstream) immediately upon waking, and then have 
another urine sample collected 1 h afterwards. Besides, 
our study population consisted of active-duty police-
men, working in a shift work system, which rendered 
a 24-h urine collection non-feasible. As plasma cortisol 
concentration is at its highest 30–45 min after waking 
up, we measured cortisol in the urine samples obtained 
from the second emptying of the bladder (1 h after wak-
ing up). All urine samples were collected at home, while 
in the laboratory they were centrifuged for 10  min at 
3500 rpm. The samples of urine, separated plasma, and 
serum were stored at − 80 °C for 3–4 months, pending 
assays.
Total cholesterol and triglycerides were determined 
by an enzymatic method, while LDL cholesterol was cal-
culated with the Friedewald formula. Basic biochemical 
tests (liver enzymes, glucose, urea, uric acid and creati-
nine (serum, urine) were carried out with the aid of Vit-
ros 350 Chemistry System (Ortho Clinical Diagnostics). 
Fibrinogen level in plasma was determined by coagu-
lometry using the BCT camera (Behring Coagulation 
Timer, Dade-Behring, Germany) and the Multifibren U 
kit. Ultrasensitive CRP (hs-CRP) in the serum was deter-
mined by nephelometry (BN II System, Siemens), using 
CardioPhase assay (Siemens Healthcare Diagnostics 
Products GmbH, Marburg, Germany). Tissue necrotic 
factor-α (TNF-α) in the plasma was measured by ELISA 
(Quantikine HS Human TNF-α, R&D Systems, England). 
Cortisol level in the urine samples was determined by a 
commercially available enzyme-linked immunosorbent 
assay (ELISA Cortisol Assay, R&D Systems, England) 
with absorbance detection (BioTek Synergy HTX Multi-
Mode Microplate Reader, USA). Urinary content of cor-
tisol was expressed as ng/mg of creatinine. The intra- and 
inter-assay coefficients of variation were 6.3% and 8.3%, 
respectively.
Insulin in the serum was determined by an immu-
noassay using a commercial kit (Insulin ELISA, DRG 
Instruments GmbH; Germany). HOMA-IR index was 
calculated as fasting insulin x fasting glucose/22.5. Value 
of HOMA-IR > 80‰ designated in the subgroup of police 
officers (n = 33) without any metabolic abnormalities 
was assumed the threshold of IR, i.e. 2.04. The intra- and 
inter-assay coefficients of variation were 3.7% and 5.3%, 
respectively.
Plasma free isoprostane 8-iso-PGF2α was determined 
by gas chromatography coupled with mass spectrometry 
(GC–MS) [19]. In order to prevent artefactual oxidation 
ex vivo, 25 µl of 1% butylated hydroxytoluene (BHT) was 
added to 1 ml of plasma. The measurements were carried 
out using a mass spectrometer (MS Engine 5989B Hewlet 
Packard, Palo Alta, CA, USA) connected to a gas chro-
matograph (GC 5890 series II Hewlet Packard, Palo Alta, 
CA, USA). The intra- and inter-assay coefficients of vari-
ation were 3.35% and 5.82%, respectively.
Statistical analysis
The normality of data distribution was verified using the 
Shapiro–Wilk’s test. Continuous variables are presented 
as median and 95% confidence interval (CI). For com-
parison of the variables between groups, due to lack of 
normality, the Mann–Whitney U test was applied. Cate-
gorical data were expressed as frequencies (percentages), 
and their differences analysed using the Chi square test. 
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In the regression models, glucose was not considered, as 
it was included in the HOMA-IR formula. Univariate and 
multivariate regression models were applied to assess 
the relationships between the indices of psychological 
stress with oxidative stress marker, and HOMA-IR. The 
associations with HOMA-IR were also assessed in the 
regression model comprising urine cortisol, plasma 8-iso-
PGF2α, and the variables whose values, when exceeding 
the reference range (i.e. abnormal), are deemed the key 
identification attributes of MetS (waist circumference, 
triglycerides, HDL cholesterol, systolic blood pressure).
To assess the impact of variables (cortisol, 8-iso-PGF2α, 
atherogenic dyslipidemia, MetS and its components) 
on the incidence of IR, logistic regression models were 
applied. In the logistic regression models, cortisol and 
8-iso-PGF2α were used as the continuous, while athero-
genic dyslipidemia, MetS, and its components were used 
as the dichotomous, independent variables. The result-
ing odds ratios (ORs) and 95% confidence intervals (CIs) 
were reported. The multivariate regression models were 
adjusted for age, sex, and current smoking. In multi-
variate models, multicollinearity was not evidenced. For 
evaluating the correlations between respective variables, 
Spearman’s rank correlation coefficient was applied. 
P < 0.05 indicated statistical significance. Statistical analy-
sis was pursued with STATISTICA 13.1 PL.
Results
Clinical characteristics of the study subjects strati-
fied by IR status are presented in Table  1. The IR sub-
jects, as compared to the non-IR ones, showed higher 
(although not significantly; p = 0.06) prevalence of sta-
ble CHD, diagnosed through typical clinical coronary 
symptoms and positive exercise ECG testing (Table  1). 
Coronary artery plaques were found in 32 (33.33%) in 
the IR, and 13 (21.31%) in the non-IR subjects (p = n.s.). 
Only carotid IMT value was significantly higher in the IR 
group (p = 0.001), as evidenced by the ultrasound imag-
ing measurements. The respective groups (IR vs. non-IR) 
differed in FRS (p = 0.0001), BMI (p < 0.0001), and waist/
hip ratio  (p < 0.0001). More overweight subjects were 
found in the non-IR group (50% vs. 34.64%, p = 0.02), 
whereas the number of obesity subjects was higher in the 
IR group (59.05% vs. 23.12%, p < 0.0001). Out of overall 
study population, 45 subjects had atherogenic dyslipi-
demia (28.35% in the IR group, and 8.03% in the non-IR 
group; p < 0.0001), 110 had MetS (67.71% in the IR group 
and 21.42% in the non-IR group; p < 0.0001), whereas 136 
of them were hypertensive (71.31% in the IR group and 
43.75% in the non-IR group, p < 0.0001).
In the non-IR subjects, only in 20 (9.09%) of them 
HOMA-IR value was ≤ 1.0. Also, the respective groups 
(IR vs. non-IR) significantly differed in the variables 
whose values, when exceeding the reference range (i.e. 
abnormal), are acknowledged the key identification 
attributes of MetS (i.e., HDL cholesterol, triglycerides, 
glucose, blood pressure, and waist circumference (not 
comprised in the table). Furthermore, the levels of pro-
inflammatory markers (CRP, TNF-α) were also sig-
nificantly higher in the IR subjects, as compared to the 
non-IR ones (Table 1).
The median (95% CI) level of perceived stress was 
17.00 (15.73, 18.27), and 16.0 (14.86, 17.30), (p = n.s.) 
for the IR and non-IR subjects, respectively. Urine 
median (95% CI) cortisol (calculated as ng/mg of creati-
nine) was significantly higher in the IR subjects [119.70 
(105.01, 134.40) vs. 89.80 (76.90, 102.69), p < 0.001]. The 
IR subjects also had significantly higher plasma median 
(95% CI) 8-iso-PGF2α level, as compared to the non-IR 
ones [7.60 (6.55, 8.03) pg/mL vs. 6.39 (5.21, 6,56) pg/
mL, p = 0.04]. The results of univariate analyses regard-
ing the associations between the indices of psychologi-
cal stress (PSS, cortisol) and oxidative stress marker are 
presented in Table  2. A positive association between 
the perceived stress level and cortisol was established 
[B = 2.150, 95% CI (0.212, 4.097), p = 0.03], and both 
psychological stress indices were positively associated 
with plasma 8-iso-PGF2α [B = 0.139, 95% CI (0.048, 
0.230), p = 0.002, and B = 0.007, 95% CI (0.0006, 0.014), 
p = 0.03; for PSS score and cortisol, respectively].
As evidenced in the univariate analysis, HOMA-IR 
value was associated with plasma 8-iso-PGF2α level 
[B = 0.069, 95% CI (0.016, 0.120), p = 0.01], whereas 
with respect to both psychological stress indices, 
such an association was confirmed for cortisol only 
[B = 0.003, 95% CI (0.0003, 0.005), p = 0.02] (Table  3). 
In the multivariate models (comprising plasma 8-iso-
PGF2α, urine cortisol, PSS score), adjusted for age, sex, 
and current smoking, 8-iso-PGF2α was associated with 
HOMA-IR [B = 0.068; 95% CI (0.007, 0.129), p = 0.02], 
whereas the association between cortisol and HOMA-
IR approximated the significance level (B = 0.002, 95% 
CI [-0.0003, 0.005], p = 0.06; Table  3). No associations 
were established between PSS score and HOMA-
IR (B = 0.007, 95% Cl [-0.028, 0.043], p = 0.67 and 
B = -0.013, 95% CI [-0.050, 0.023], p = 0.48), neither in 
univariate, nor multivariate analyses.
As evidenced in Table  4, the associations of 8-iso-
PGF2α (B = 0.032, 95% CI [-0.013, 0.078], p = 0.11) and 
cortisol (B = 0.001, 95% CI [-0.0007, 0.003], p = 0.18) with 
HOMA-IR became non-significant. Out of the variables 
addressed in the regression model, waist circumference 
(B = 0.056, 95% CI [0.039, 0.074], p < 0.0001) and sys-
tolic blood pressure (B = 0.009, 95% CI [0.00003, 0.018], 
p = 0.04) were positively associated with HOMA-IR, 
whereas the association of HDL cholesterol (B = -0.597, 
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Table 1 Characteristics of the study subjects, as stratified by insulin resistance status
Data are expressed as no. (%), or median (95% CI)
Framingham Risk Score, 10-year risk of developing coronary heart disease; CHD coronary heart disease, BMI body mass index, W/H waist/hip, FMD flow-mediated 
dilation, cIMT carotid intima-media thickness, LDL low density lipoprotein, HDL high density lipoprotein, CRP C-reactive protein, 8-iso-PGF2α 8-iso-prostaglandin  F2α, 
TNF-α tissue necrotic factor-α, SBP (DBP) systolic (diastolic) blood pressure, HOMA-IR the homeostasis model assessment of insulin resistance, PSS perceived stress 
scale, ALT alanine aminotransferase, AST aspartate aminotransferase
a n (%) subjects who underwent computed tomography coronary angiography
Variable Insulin resistance No insulin resistance p
N (F) 122 (7) 112 (12)
Age; years 41.00 (39.62, 42.38) 40.00 (38.52, 41.47) 0.39
Metabolic syndrome; n (%) 86 (67.71) 24 (21.42%) < 0.0001
Atherogenic dyslipidemia; n (%) 36 (28.35) 9 (8.03) 0.0001
FRS 5.40 (4.26, 6.53) 3.20 (2.22, 4.17) 0.0001
BMI; kg/m2 31.44 (30.55, 32.32) 27.75 (26.95, 28.55) < 0.0001
W/H ratio 0.977 (0.973, 0.990) 0.91 (0.895, 0.926) < 0.0001
Overweight; n (%) 44 (34.64) 58 (51.78) 0.01
Obesity; n (%) 78 (61.42) 25 (23.21) < 0.0001
Stable CHD, n (%) 13 (10.23%) 4 (3.57%) 0.06
Coronary plaque; n (%)a 32 (33.33) 13 (21.31) 0.11
Hypertension; n(%) 87 (71.31) 49 (43.75) < 0.0001
Current smoking; n (%) 42 (33.07) 35 (31.25) 0.98
Total cholesterol; mmol/L 5.40 (5.18, 5.61) 5.05 (4.81, 5.28) 0.08
LDL cholesterol; mmol/L 3.12 (2.94, 3.30) 2.99 (2.80, 3.17) 0.32
HDL cholesterol; mmol/L 1.20 (1.15, 1.24) 1.29 (1.25, 1.34) 0.01
Triglycerides, mmol/L 2.05 (1.68, 2.42) 1.34 (1.05, 1.62) < 0.001
Glucose; mmol/L 5.40 (5.24, 5.57) 5.10 (4.99, 5.20) < 0.0001
ALT; U/L 44.00 (40,49, 49.50) 38.00 (32,82, 39.77) 0.002
AST; U/L 34.00 (31.89, 36.90) 30.00 (28.07, 31.37) 0.002
Total bilirubin; µmol/L 12.00 (10.42, 13.57) 13.00 (11.53, 14.46) 0.16
Uric acid; µmol/L 378.00 (359.61, 396.38) 334.50 (315.95, 353.04) < 0.0001
Serum creatinine; µmol/L 91.00 (87.78, 94.21) 89.00 (85.84, 92.15) 0.30
SBP; mm Hg 135.00 (131.40, 138.66) 120.00 (115.92, 124.07) < 0.0001
DBP; mm Hg 85.00 (82.65, 87.35) 80.00 (76.56, 82.43) 0.0009
cIMT; mm 0.56 (0.550, 0.571) 0.54 (0.535, 0.547) 0.001
FMD; % 7.08 (6.30, 7.85) 7.57 (6.75, 8.38) 0.31
CRP; mg/L 1.29 (1.229, 1.36) 0.88 (0.53, 1.23) 0.0001
TNF‑α; pg/mL 0.92 (0.90, 0.94) 0.82 (0.74, 0.89) 0.02
Fibrinogen; g/L 3.30 (3.11, 3.48) 3.20 (3.01, 3.38) 0.61
Insulin; µIU/mL 23.82 (20.10, 27.54) 11.37 (10.55, 12.18) < 0.0001
HOMA‑IR 3.02 (2.78, 3.26) 1.46 (1.35, 1.56) < 0.0001
Plasma 8‑iso‑PGF2α; pg/mL 7.60 (6.55, 8.03) 6.39 (5.21, 6,56) 0.04
Urine cortisol; ng/mg of creatinine 119.70 (105.01, 134.40) 89.80 (76.90, 102.69) < 0.001
PSS‑10 score 17.00 (15.73, 18.27) 16.0 (14.86, 17.30) 0.62
Medications, n (%)
Aspirin 1 (0.82) 5 (4.46) 0.07
 ACEI/ARB 31 (25.40) 10 (8.93) 0.001
 β‑blocker 28 (22.95) 12 (10.71) 0.01
 Ca‑blocker 10 (8.10) 3 (2.68) 0.05
 Diuretics 22 (18.03) 5 (4.46) 0.001
 Lipid‑lowering agents 7 (5.74) 4 (3.57) 0.43
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95% CI [-1.139, -0.055], p = 0.03) was a negative one 
(Table 4).
Crude and adjusted OR regarding the impact of cor-
tisol, 8-iso-PGF2α, atherogenic dyslipidemia and MetS 
(per se), as well as the MetS components, on the inci-
dence of IR, are presented in Tables  5 and 6. In the 
univariate model, cortisol (OR = 1.007, 95% CI [1.002, 
1.012], p = 0.006), and 8-iso-PGF2α (OR = 1.103, 95% 
CI [1.010, 1.201], p = 0.02) affected the incidence of IR. 
Even though the effect of plasma 8-iso-PGF2α was small, 
it nevertheless increased the chances for the incidence of 
IR by 10%. MetS (as a binary variable) had the strongest 
impact on the incidence of IR (OR = 6.828, 95% CI [3.775, 
12.354], p < 0.00001), while atherogenic dyslipidemia (as 
a binary variable) also proved significant (OR = 3.511, 
95% CI [1.634, 7.553], p = 0.001) (Table 5). In the multi-
variate logistic regression model, adjusted for age, sex, 
current smoking, and atherogenic dyslipidemia, the 
impact of cortisol [OR = 1.006, 95% CI (1.001, 1.011), 
p = 0.01] and 8-iso-PGF2α [OR = 1.011, 95% CI (1.002, 
1.213), p = 0.04] on the incidence IR was still significant. 
On the other hand, after adjustment for MetS, instead of 
atherogenic dyslipidemia, age, sex, and current smoking 
Table 2 Associations between the indices of psychological 
stress and oxidative stress marker in univariate analyses
B unstandardized coefficient, CI confidence interval, 8-iso-PGF2α 8-iso-
prostaglandin  F2α
Cortisol PSS scores
B (95% CI) p B (95% CI) p
8‑iso‑PGF2α 0.007 (0.0006, 0.014) 0.03 0.139 (0.048, 0.230) 0.002
Cortisol – – 2.150 (0.202, 4.097) 0.03
Table 3 Associations between the indices of psychological 
stress and oxidative stress marker with HOMA-IR
B unstandardized coefficient, CI confidence interval, HOMA-IR the homeostasis 
model assessment of IR, 8-iso-PGF2α 8-iso-prostaglandin  F2α
# Multivariate regression model comprised cortisol, PSS score, 8-iso-PGF2α, 
adjusted for age, sex, and current smoking
B (95% CI) p
8‑iso‑PGF2α 0.069 (0.016, 0.120) 0.01
0.068 (0.007, 0.129) 0.02#
Cortisol 0.003 (0.0003, 0.005) 0.02
0.002 (− 0.0003, 0.005) 0.06#
PSS scores 0.007 (− 0.028, 0.043) 0.67
− 0.013 (− 0.050, 0.023) 0.48#
Table 4 Associations of  select variables with  HOMA-IR 
in multivariate analysis
Multivariate regression model comprised of the variables whose values, 
when exceeding the reference range (i.e. abnormal), are the key identification 
attributes of metabolic syndrome (apart from glucose), cortisol, and 8-iso-PGF2α, 
adjusted for age, sex, and current smoking
B unstandardized coefficient, CI confidence interval, SBP systolic blood pressure, 
8-iso-PGF2α 8-iso-prostaglandin  F2α
Variable B (95% CI) p
Waist circumference 0.056 (0.039, 0.074) < 0.0001
Triglycerides − 0.531 (− 0.174, 0.069) 0.39
HDL cholesterol − 0.597 (− 1.139, − 0.055) 0.03
SBP 0.009 (0.00003, 0.018) 0.04
8‑iso‑PGF2α 0.032 (− 0.013, 0.078) 0.11
Cortisol 0.001 (− 0.0007, 0.003) 0.18
Table 5 Odds ratios for the incidence of insulin resistance
OR odds ratio, CI confidence interval, 8-iso-PGF2α 8-iso-prostaglandin  F2α
# Multivariate regression model comprised 8-iso-PGF2α, cortisol, atherogenic 
dyslipidemia (yes/no), adjusted for age, sex, and current smoking
¶ Multivariate regression model comprised 8-iso-PGF2α, cortisol, metabolic 
syndrome (yes/no), adjusted for age, sex, and current smoking
Variable OR (95% CI) p
8‑iso‑PGF2α 1.103 (1.010, 1.203) 0.02
1.011 (1.002, 1.213) 0.04#
1.017 (0.922, 1.120) 0.72¶
Cortisol 1.007 (1.002, 1.012) 0.006
1.006 (1.001, 1.011) 0.01#
1.004 (0.999, 1.010) 0.08¶
Atherogenic dyslipidemia 3.511 (1.634, 7.553) 0.001
Metabolic syndrome 6.828 (3.775, 12.354) < 0.00001
Table 6 Odds ratios for  insulin resistance relative 
to  metabolic syndrome components, cortisol, and  8-iso-
PGF2α
OR odds ratio, CI confidence interval, 8-iso-PGF2α 8-iso-prostaglandin  F2α
# Baseline model, cortisol, and 8-iso-PGF2α adjusted for age, sex, and current 
smoking
a ≥94/80 cm (men/women). Baseline model comprised of metabolic syndrome 
components, except elevated fasting plasma glucose, as glucose was already 
included in the HOMA-IR formula
Variable OR (95% CI) p
Waist  circumferencea 4.966 (2.29, 10.75) 0.00004
3.621 (1.602, 8.182) 0.001#
High blood pressure 1.860 (0.976, 3.542) 0.05
1.940 (0.966, 3.896) 0.06#
Hypertriglyceridemia 1.993 (1.063, 3.736) 0.03
2.012 (1.025, 3.949) 0.04#
Low HDL cholesterol 1.472 (0.706, 3.068) 0.29
1.568 (0.726, 3.386) 0.24#
8‑iso‑PGF2α 1.055 (0.953, 1.168) 0.29
#
Cortisol 1.005 (0.999, 1.100) 0.10#
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as the correcting variables, the effects of 8-iso-PGF2α 
[OR = 1.017, 95% Cl (0.922, 1.120), p = 0.72] and corti-
sol [OR = 1.004, 95% CI (0.999, 1.010), p = 0.08] became 
attenuated, and consequently non-significant (Table 5).
In turn, in the multivariate logistic regression model, 
taking into account the MetS components, cortisol, and 
8-iso-PGF2α, only waist circumference [OR 4.966, 95% 
CI (2.29, 10.751), p = 0.00004] and hypertriglyceridemia 
[OR 1.993, 95% CI (1.063, 3.736), p = 0.03] affected the 
incidence of IR, while the effect of high blood pressure 
approached the significance level [OR 1.860, 95% CI 
(0.976, 3.542), p = 0.05] (Table  6). Following additional 
adjustment for age, sex, and current smoking, these asso-
ciations persisted.
In the univariate models, it was established that 
plasma 8-iso-PGF2α level was positively associated 
with systolic blood pressure [B = 0.032, 95% Cl (0.008, 
0.055), p = 0.008], waist circumference [B = 0.047, 95% 
Cl (0.011, 0.083), p = 0.01], and CRP level [B = 0.257, 
95% Cl (0.014, 0.502), p = 0.03]. Positive associations 
between both inflammatory markers and waist circum-
ference [B = 0.053, 95% Cl (0.034, 0.071) p < 0.0001, and 
B = 0.026, 95% Cl (0.0005, 0.052) p = 0.04; for CRP and 
TNF-α, respectively] were also corroborated (data not 
comprised in the table).
No correlation was established between the level of 
perceived stress and inflammatory markers (ρ = 0.02, 
p = 0.80, and ρ = 0.02, p = 0.75, for CRP and TNF-α, 
respectively), while urine cortisol positively correlated 
with CRP only (ρ = 0.21, p = 0.001). Both inflamma-
tory markers positively correlated with HOMA-IR value 
(ρ = 0.26, p < 0.0001, and ρ = 0.16, p = 0.01, for CRP and 
TNF-α, respectively). Neither were there any correla-
tions established between the actual duration of police 
work and PSS score (ρ = 0.002, p = 0.97), urine cortisol 
(ρ = -0.07, p = 0.25), plasma 8-iso-PGF2α level (ρ = 0.009, 
p = 0.88), and HOMA-IR (ρ = -0.09, p = 0.15) value (data 
not comprised in the table).
Discussion
In the present cross-sectional study, positive associa-
tions between the indices of psychological stress, i.e. self-
reported perceived stress, and cortisol (biological stress 
marker) with plasma 8-iso-PGF2α were established. We 
also demonstrated the associations of cortisol and plasma 
oxidative stress marker with HOMA-IR and the inci-
dence of IR in the subjects exposed to a highly stressful 
occupation.
Studies on rodents and humans give grounds to the 
belief that oxidative stress is an important trigger for 
IR, while research in humans regarding the associa-
tion between psychological stress and oxidative stress 
is generally scarce [13, 15, 20–22]. Perceived stress in 
the pre-menopausal caregiving women was not related 
to urine isoprostanes, but to the oxidative stress index 
[20]. Also, in the study of Shimanoe et  al. the asso-
ciation between perceived stress and the excretion of 
8-hydroxydeoxyguanosine (oxidative damage DNA 
marker) in urine was established as a weak one [22].
Even though no significant difference in perceived 
stress between respective groups was established, the 
mean values of PSS score in IR and non-IR subjects were 
higher than in the other populations under study, whilst 
remaining in full compliance with the norms proposed 
by Cohen [23, 24]. The mean score of perceived stress 
in our IR subjects was also higher (17.08; 42.70%) than 
in the Lesage et al. study of population aged 41-50 years 
(16.1; 40.25%) [24]. In the two studies on police officers 
perceived stress values (as assessed by PSS-10, or PSS-
14 scale) were lower than in our own study. In a Chinese 
study, only women participated, as well as were younger 
than our population, while in the Midwestern police 
force officers study, only about 61% of the study popula-
tion were active duty policemen [25, 26].
A positive association between the scores of perceived 
stress and urine cortisol levels in our population was also 
demonstrated in other studies focused on police officers 
[27, 28]. On the other hand, Mikkelsen et  al. in a large 
cohort study of Danish public service employees, found 
neither any cross-sectional, nor any longitudinal impact 
of prolonged perceived stress on the level on morning 
salivary cortisol [29]. Plasma, as well as salivary cortisol 
levels were found higher prior to an anticipatory emo-
tional/cognitive threat, as well as in response to acute 
mental stress in firefighters and police officers, as com-
pared to the controls [30–32].
Positive relationships between the self-reported per-
ceived stress and cortisol with plasma 8-iso-PGF2α, as 
well as the association between both psychological stress 
indices seem to point to a possible link between the acti-
vation HPA response to psychological stressors and met-
abolic cortisol effects. We construe the results yielded 
by the present study in the light of the hypothesis pro-
posed by Aschbacher et  al. whereby “heightened antici-
patory cortisol reactivity would mediate the relationship 
between perceived stress and elevated oxidative stress 
damage”. It was documented that heightened anticipatory 
salivary cortisol responses to psychological stress were 
associated with the higher levels of plasma 8-iso-PGF2α 
[33].
Besides, the urine samples had been taken before their 
shift, higher urine cortisol levels in the IR subjects may 
indicate greater anticipatory cortisol response, and may 
therefore be well indicative of the links between the per-
ceived psychological stress and an increased susceptibil-
ity to oxidative stress, e.g. increased plasma 8-iso-PGF2a 
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may appear appreciably later than the adrenal cortisol 
release. Furthermore, it was suggested that urinary free 
cortisol excretion at the night-time period and early 
morning hours were most likely an optimal time frame 
for investigating the subtle alterations of the HPA axis 
activity in obese individuals [34]. Response to stress-
ors and their effect on cortisol secretion may, to some 
extent, be attributable to both the actual type, and per-
ceived intensity of the stressor by an individual officer, 
i.e. a “stimulus response specificity”, and that events or 
conditions considered highly stressful by the police offic-
ers may be associated with the disturbances of a typical 
awakening cortisol pattern [35, 36].
In contrast to our cross-sectional study of non-diabetic 
population, self-perceived stress was an independent pre-
dictor of incident type 2 diabetes in long term follow-up 
study of Novak et  al. [4]. Also, in yet another recently 
published study, perceived stress emerged as a signifi-
cant predictor of type 2 diabetes mellitus, even though 
the association of PSS score with HOMA-IR was not 
assessed [7]. On the other hand, subclinical hypercorti-
solism in elderly patients with type 2 diabetes, as well as 
higher urinary free cortisol in overweight girls, associ-
ated with visceral adiposity and IR, was reported [37, 38].
Joseph et al. demonstrated, that cortisol curve features 
were, paradoxically, associated with lower HOMA-IR 
in the non-diabetic participants [38, 39]. In the normo-
glycemic subjects, cortisol inhibits insulin release, while 
chronic psychological stress may impair the feedback 
mechanisms which return these hormonal systems to 
normal, resulting in chronic elevation in cortisol levels 
[9]. Our subjects with weight gain/body fat may lose the 
beneficial effect of the interaction between cortisol and 
the adipoinsular axis, which consequently accounts for 
the detrimental effects of cortisol, including lipolysis, 
IR, and other metabolic effects [39]. This hypothesis is 
supported by Darmon et  al. in whose study a low-dose 
hydrocortisone infusion, administered to simulate mild 
stress, developed markedly greater IR in abdominally 
obese participants, as compared to normal BMI controls 
[40]. Measurement of single-point urine cortisol only 
may be less sensitive in terms of detecting subtle differ-
ences in subclinical hypercortisolism, and not actually 
reflect the total cortisol load. We did nevertheless man-
age to demonstrate its association with oxidative stress 
and HOMA-IR.
The oxidative stress markers were found higher in the 
animal study [41]. Data pertaining to the relationship 
between oxidative stress and IR in humans are scarce, 
and none are specifically focused on police officers [15, 
17, 21]. In the present study, plasma 8-iso-PGF2α was 
positively related to HOMA-IR, and increased by 10% 
the chance of IR incidence in a middle-aged population 
burdened with psychological stress. Atherogenic dys-
lipidemia (higher triglycerides and low HDL cholesterol) 
often precedes the full clinical manifestation of MetS, 
and is associated with IR. When adjusting for it, however, 
the impact of oxidative stress marker on IR incidence was 
still evident. MetS, and waist circumference (originating 
in its components), most manifestly affected the develop-
ment of IR, as corroborated by other investigators [15–
17]. After adjustment for BMI, or waist circumference, 
no relationships plasma F2-isoprostanes with HOMA-IR 
were reported in longitudinal Park et  al. study, while in 
the other a cross-sectional study, relationship of urine 
8-iso-PGF2α was established as BMI-independent with 
regard to HOMA-IR only, although not with regard to IR 
[15, 21].
In the highly developed countries, IR occurs in 24–50% 
of adults, and remains consistently on the rise. To the 
best of our knowledge, the present study is the first one 
ever to highlight the interrelationships between oxidative 
stress and IR, which may well be regarded as the meta-
bolic consequences of psychological stress in police offic-
ers. In contrast to physiological conditions, in a stressful 
situation, anabolic-catabolic imbalance (high cortisol, 
insulin) and low concentration of the opposite hormones, 
may lead to oxidative stress, systemic inflammation, and 
IR. Excessive caloric intake and low energy expenditure 
increase ROS production in the mitochondria [42]. It is 
also well-worth noting that ingestion of calories-rich 
foods during stressful periods contributes to obesity, 
which also plays a key role in the development of IR.
The exact pathomechanism of oxidative stress being 
instrumental in IR development has not yet been fully 
elucidated, although acknowledged to entail a disruption 
of complex network of insulin signalling pathways. Meta-
bolic disturbances (i.e. enhanced plasma fatty acids level, 
hyperglycaemia and hyperinsulinemia) in peripheral IR 
also promote of IR brain and neurotoxicity, which may 
manifest themselves through the disturbances in neuro-
transmitter’s release and uptake [43]. ROS also stimulate 
a pro-inflammatory signalling pathway, linking oxidative 
stress with an inflammatory state and IR. Both inflam-
matory markers (CRP, TNF-α) were positively associ-
ated with waist circumference (obesity indicator) in the 
study subjects. An enhanced production of TNF-α by 
adipocytes induce liver CRP synthesis in obese subjects, 
indicating an activation of a pro-inflammatory signalling 
pathway, which may have contributed to the develop-
ment of IR.
The correlations between plasma inflammatory mark-
ers and HOMA-IR in present study were also docu-
mented. Positive association between 8-iso-PGF2α and 
CRP, as established throughout our study, remains well 
in line with the findings of Black et  al. [44]. This is an 
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important observation, as CRP is involved in the progres-
sion of atherosclerosis at every stage of its development, 
as well as contributes to CVD risk. The bidirectional 
association between oxidative stress and inflammation is 
also demonstrated by other investigators [45, 46]. On the 
other hand, reduction of ROS production enhances both 
mitochondrial function, and insulin sensitivity [47].
Our study revealed frequent incidence of metabolic 
CVD risk factors, and the links of psychological and 
oxidative stress with IR in police officers. It follows that 
implementation of an integrated prevention strategy, 
based on a systematic evaluation of the total risk of a 
disease at an individual level, appears essential for this 
particular occupational group. The subjects at risk would 
then be identified much earlier in the course of a vascu-
lar disease, while the attendant risk factors would stand 
a good chance of being mitigated, while clinical manifes-
tations of CVD, as well as other consequences of obesity 
and MetS might also be appreciably reduced through 
adequate control regimen.
Limitations
Several likely limitations of the present study need to be 
acknowledged. Firstly, we are aware that the methods 
used to assess psychological stress in our study may not 
reflect the actual level of stress in the population sam-
ple. We assessed the subjective stress perception, even 
though we were unable to evaluate any specific sources 
of stress in the actual police work, for reasons beyond our 
control. Secondly, we addressed one marker of oxidative 
stress only, without pursuing assessment of antioxidative 
enzymes and other antioxidative substance which would 
provide information about the redox homeostasis in vivo. 
Thirdly, in our cohort of police officers, only a single-
point urine cortisol measurement was taken.
Admittedly, measuring the trajectory of morning sali-
vary cortisol (or diurnal cortisol secretion), might well 
yield more information on total cortisol load, as well as 
on the actual nature of the relationships under study. 
Fourthly, the cut-off HOMA-IR value in the present 
study was 2.04 (see the Methods section), based on the 
receiver operating characteristics (ROC) analysis. In 
other studies, various HOMA-IR cut-off values were 
used to determine IR, e.g. in the study by Gayoso-Diz 
et  al. the cut-off values were 1.60 vs. 2.05 for diabetic 
and non-diabetic men with MetS, respectively (defined 
in line with IDF criteria) [48]. Furthermore, the study 
subjects differed in their CVD risk factors and medi-
cation intake which might also affect the results. The 
results of our own study may not stand an effective 
comparison with other studies for several reasons, 
e.g. substantial differences in the populations under 
study, age, and other concomitant metabolic disorders. 
Finally, as the present study is of a cross-sectional 
design, the actual causal relationships do not really lend 
themselves to accurate inferences.
Conclusions
To the best of our knowledge, the present study is the 
first one to highlight the interrelationships between oxi-
dative stress and IR, which may well be regarded as the 
metabolic consequences of psychological stress, as psy-
chological stress was associated with an oxidative one. In 
the subjects exposed to frequent/chronic psychological 
stressors, cortisol, and oxidative stress marker were asso-
ciated with IR, being statistically attenuated, though, fol-
lowing adjustment for MetS or its components. Further 
studies are nevertheless required to have these findings 
effectively corroborated, also with a view to addressing 
any potential relationships between different variables.
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